Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
VG Life Sciences, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'VG Life Sciences, Inc. - Product Pipeline Review - 2014', provides an overview of the VG Life Sciences, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of VG Life Sciences, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of VG Life Sciences, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of VG Life Sciences, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the VG Life Sciences, Inc.'s pipeline products Reasons to buy - Evaluate VG Life Sciences, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of VG Life Sciences, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the VG Life Sciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of VG Life Sciences, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of VG Life Sciences, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of VG Life Sciences, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 VG Life Sciences, Inc. Snapshot 4 VG Life Sciences, Inc. Overview 4 Key Information 4 Key Facts 4 VG Life Sciences, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 VG Life Sciences, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Combination Treatment Modalities 9 VG Life Sciences, Inc. - Pipeline Products Glance 10 VG Life Sciences, Inc. - Clinical Stage Pipeline Products 10 Phase I Products/Combination Treatment Modalities 10 VG Life Sciences, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Discovery Products/Combination Treatment Modalities 12 VG Life Sciences, Inc. - Drug Profiles 13 hydroxychloroquine + sorafenib tosylate 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 VGV-L 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 VGV-S 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 VGV-X 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 sodium dichloroacetate 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 VG Life Sciences, Inc. - Pipeline Analysis 19 VG Life Sciences, Inc. - Pipeline Products by Target 19 VG Life Sciences, Inc. - Pipeline Analysis 21 VG Life Sciences, Inc. - Pipeline Products by Route of Administration 21 VG Life Sciences, Inc. - Pipeline Products by Molecule Type 22 VG Life Sciences, Inc. - Pipeline Products by Mechanism of Action 23 VG Life Sciences, Inc. - Recent Pipeline Updates 25 VG Life Sciences, Inc. - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 29 Disclaimer 29
List of Tables VG Life Sciences, Inc., Key Information 4 VG Life Sciences, Inc., Key Facts 4 VG Life Sciences, Inc. - Pipeline by Indication, 2014 6 VG Life Sciences, Inc. - Pipeline by Stage of Development, 2014 7 VG Life Sciences, Inc. - Monotherapy Products in Pipeline, 2014 8 VG Life Sciences, Inc. - Combination Treatment Modalities in Pipeline, 2014 9 VG Life Sciences, Inc. - Phase I, 2014 10 VG Life Sciences, Inc. - Preclinical, 2014 11 VG Life Sciences, Inc. - Discovery, 2014 12 VG Life Sciences, Inc. - Pipeline by Target, 2014 20 VG Life Sciences, Inc. - Pipeline by Route of Administration, 2014 21 VG Life Sciences, Inc. - Pipeline by Molecule Type, 2014 22 VG Life Sciences, Inc. - Pipeline Products by Mechanism of Action, 2014 24 VG Life Sciences, Inc. - Recent Pipeline Updates, 2014 25
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.